Hatem Elalfy

Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19

Hatem Elalfy, Tarek Besheer, Ahmed El‐Mesery et al. · Journal of Medical Virology · 2021 · 71 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients

Mustafa Neamatallah, Mahmoud El‐Bendary, Hatem Elalfy et al. · Immunological Investigations · 2019 · 48 citations

Medicine, Infectious Diseases, Molecular Genetics +17

The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection

Mahmoud El‐Bendary, Mustafa Neamatallah, Hatem Elalfy et al. · British Journal of Biomedical Science · 2018 · 44 citations

Life Sciences, Genetics, Infectious Diseases +16

Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors

Tarek Besheer, Mahmoud El‐Bendary, Hatem Elalfy et al. · Journal of Interferon & Cytokine Research · 2017 · 42 citations

Medicine, Genetics, Molecular Genetics +17

RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study

Mahmoud El‐Bendary, Sherief Abd‐Elsalam, Tamer Elbaz et al. · Expert Review of Anti-infective Therapy · 2021 · 40 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14